Canadian Urological Association-Canadian Urologic Oncology Group Guideline on Metastatic Castration-Naive and Castration-Sensitive Prostate Cancer

This is a clinical practice guideline for patients with metastatic prostate cancer. The guideline examines various therapies for the treatment of metastatic castration-naive and castration-sensitive prostate cancer, including androgen-deprivation therapy, as well as local and external therapies. The prevention of osteoporosis, as well as opportunities for multidisciplinary consultation, are also discussed.